ADM Endeavors, Inc.

ADM Endeavors, Inc. operates as Cardima, a medical device company specializing in the diagnosis and treatment of cardiac arrhythmias. Cardiac arrhythmias are conditions caused by abnormal electrical currents in the heart, leading to fast, slow, or irregular heartbeats, which can be symptomatic and associated with significant health issues or even death. The company's products primarily address atrial fibrillation (AF) and ventricular tachycardia (VT), with AF being the focus of most clinical and commercial efforts. ADM Endeavors' product portfolio includes the PATHFINDER® and REVELATION® Series of diagnostic catheters, the VUEPORT® and NAVIPORT® Series of guiding catheters, the INTELLITEMP® Energy Management Device, and the Surgical Ablation System. All these devices have received CE mark approval and U.S. Food and Drug Administration (FDA) 510(k) clearance. The REVELATION® Series of ablation catheters, when used with the INTELLITEMP® EP Energy Management Device for treating atrial fibrillation, has CE mark approval and is sold in Europe. The INTELLITEMP® device has also received approval from the Chinese State Food and Drug Administration (SFDA) for marketing in the People's Republic of China. Key registered trademarks include PATHFINDER®, TRACER™, VUEPORT®, NAVIPORT®, REVELATION®, and INTELLITEMP®. The PATHFINDER Series of microcatheters are small, flexible wire-based devices designed for difficult procedures involving access and mapping in the coronary sinus. The company's linear ablation systems for EP and Surgical ablation deliver controlled radiofrequency (RF) energy to create thin, continuous, linear, transmural lesions.